Revelation Biosciences, Inc. (REVB)

NASDAQ: REVB · Real-Time Price · USD

0.8400

-0.0942 (-10.08%)

At close: Jan 21, 2026, 4:00 PM EST

0.8300

-0.0100 (-1.19%)

After-hours: Jan 21, 2026, 7:56 PM EST

Revelation Biosciences Employees

Revelation Biosciences had 9 employees as of December 31, 2024. The number of employees decreased by 1 or -10.00% compared to the previous year.

Employees

9

Change (1Y)

-1

Growth (1Y)

-10.00%

Revenue / Employee

n/a

Profits / Employee

-$1,564,432

Market Cap

4.98M

Employees Chart

Employees History

Date	Employees	Change (1Y)	Growth (1Y)	Full-Time	Part-Time
Dec 31, 2024	9	-1	-10.00%	8	1
Dec 31, 2023	10	4	66.67%	9	1
Dec 31, 2022	6	-	-	6	0

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

REVB News

18 hours ago - Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI - Accesswire
7 days ago - Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026) - Accesswire
9 days ago - Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Accesswire
14 days ago - Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development - Accesswire
7 weeks ago - Revelation Biosciences Has Reached A Quorum For Its December 3, 2025 Special Meeting - Accesswire
2 months ago - Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year - Accesswire
2 months ago - Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2025 - Accesswire
3 months ago - Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date - Accesswire